These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2202766)

  • 1. A novel enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies to HIV-1 envelope glycoproteins based on immobilization of viral glycoproteins in microtiter wells coated with concanavalin A.
    Robinson JE; Holton D; Liu J; McMurdo H; Murciano A; Gohd R
    J Immunol Methods; 1990 Aug; 132(1):63-71. PubMed ID: 2202766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An enzyme-linked immunosorbent assay for antibodies to the envelope glycoproteins of divergent strains of HIV-1.
    Moore JP; Wallace LA; Follett EA; McKeating JA
    AIDS; 1989 Mar; 3(3):155-63. PubMed ID: 2540772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of conserved and variant epitopes of human immunodeficiency virus type 1 (HIV-1) gp120 by human monoclonal antibodies produced by EBV-transformed cell lines.
    Robinson JE; Holton D; Pacheco-Morell S; Liu J; McMurdo H
    AIDS Res Hum Retroviruses; 1990 May; 6(5):567-79. PubMed ID: 1694449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of viral-lysate enzyme-linked immunosorbent assay kits for detecting human immunodeficiency virus (type 1) infections using human sera standardized by quantitative western blotting.
    Hardy CT; Damrow TA; Villareal DB; Kenny GE
    J Virol Methods; 1992 Jun; 37(3):259-73. PubMed ID: 1378850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocking-ELISA for detection of specific antibodies to the glycoproteins of the human immunodeficiency virus type 1 (HIV-1).
    Tardy JC; Basson J; Douglas A; Aymard M
    J Med Virol; 1990 Mar; 30(3):206-10. PubMed ID: 2187949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-directed enzyme-linked immunosorbent assay with a synthetic simian immunodeficiency virus SIVmac peptide identifying antibodies against the HIV-2 transmembrane glycoprotein.
    Norrby E; Chiodi F; Whalley A; Parks E; Nauclér A; Costa CM; Torstensson R; Biberfeld G
    AIDS; 1989 Jan; 3(1):17-20. PubMed ID: 2469436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme immunoassay (ELISA) for the evaluation of antibodies directed to the CD4 receptor-binding site of the HIV gp120 molecule.
    Hinkula J; Gidlund M; Persson C; Osterhaus A; Wahren B
    J Immunol Methods; 1994 Sep; 175(1):37-46. PubMed ID: 7523525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies to conformational epitopes of the surface glycoprotein of caprine arthritis-encephalitis virus: potential application to competitive-inhibition enzyme-linked immunosorbent assay for detecting antibodies in goat sera.
    Ozyörük F; Cheevers WP; Hullinger GA; McGuire TC; Hutton M; Knowles DP
    Clin Diagn Lab Immunol; 2001 Jan; 8(1):44-51. PubMed ID: 11139194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early and specific diagnosis of seropositivity to HIVs by an enzyme-linked immunosorbent assay using env-derived synthetic peptides.
    Fenouillet E; Sorensen AM; Lacroix M; Coutellier A; Herson S; Fretz-Foucault C; Gluckman JC
    AIDS; 1990 Nov; 4(11):1137-40. PubMed ID: 2282186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens.
    Ravanshad M; Sabahi F; Mahboudi F; Kazemnejad A
    Saudi Med J; 2006 Jan; 27(1):31-6. PubMed ID: 16432590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity and specificity of anti-HIV ELISA employing recombinant (p24, p66, gp120) and synthetic (gp41) viral antigenic peptides.
    Filice G; Soldini L; Orsolini P; Razzini E; Gulminetti R; Campisi D; Chiapparoli L; Cattaneo E; Achilli G
    Microbiologica; 1991 Jul; 14(3):185-94. PubMed ID: 1717811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New sensitive and specific assay for human immunodeficiency virus antibodies using labeled recombinant fusion protein and time-resolved fluoroimmunoassay.
    Siitari H; Turunen P; Schrimsher J; Nunn M
    J Clin Microbiol; 1990 Sep; 28(9):2022-9. PubMed ID: 2121790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic utility of a mouse monoclonal antibody (5-21-3) employed as a competitive probe in an immunoassay to detect antibody to HIV-1 gp41.
    Hunt JC; Falk L; Webber JS; Decker RH; Devare SG; Dawson GJ
    AIDS Res Hum Retroviruses; 1990 May; 6(5):599-606. PubMed ID: 1694452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and epitope mapping of neutralizing monoclonal antibodies produced by immunization with oligomeric simian immunodeficiency virus envelope protein.
    Edinger AL; Ahuja M; Sung T; Baxter KC; Haggarty B; Doms RW; Hoxie JA
    J Virol; 2000 Sep; 74(17):7922-35. PubMed ID: 10933700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine monoclonal antibodies biologically active against the amino region of HIV-1 gp120: isolation and characterization.
    Dickey C; Ziegner U; Agadjanyan MG; Srikantan V; Refaeli Y; Prabhu A; Sato A; Williams WV; Weiner DB; Ugen KE
    DNA Cell Biol; 2000 Apr; 19(4):243-52. PubMed ID: 10798448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cleavage and purification of prokaryotically expressed HIV gag and env fusion proteins for detection of HIV antibodies in the ELISA.
    Ellinger S; Mach M; Korn K; Jahn G
    Virology; 1991 Feb; 180(2):811-3. PubMed ID: 1989391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-time biospecific interaction analysis of antibody reactivity to peptides from the envelope glycoprotein, gp160, of HIV-1.
    VanCott TC; Loomis LD; Redfield RR; Birx DL
    J Immunol Methods; 1992 Feb; 146(2):163-76. PubMed ID: 1538140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation and structural analysis of soluble oligomeric gp140 envelope proteins derived from neutralization-resistant and neutralization-susceptible primary HIV type 1 isolates.
    Stamatatos L; Lim M; Cheng-Mayer C
    AIDS Res Hum Retroviruses; 2000 Jul; 16(10):981-94. PubMed ID: 10890360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Envelope sequence variability and serologic characterization of HIV type 1 group O isolates from equatorial guinea.
    Hunt JC; Golden AM; Lund JK; Gürtler LG; Zekeng L; Obiang J; Kaptué L; Hampl H; Vallari A; Devare SG
    AIDS Res Hum Retroviruses; 1997 Aug; 13(12):995-1005. PubMed ID: 9264286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of HIV-1 Virus-Like Particles expressing different HIV-1 glycoproteins.
    Visciano ML; Diomede L; Tagliamonte M; Tornesello ML; Asti V; Bomsel M; Buonaguro FM; Lopalco L; Buonaguro L
    Vaccine; 2011 Jul; 29(31):4903-12. PubMed ID: 21596074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.